Evidence map›Paper›PMID 18587394›Full record

SynthesisNature genetics2008

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.

Jeffrey C Barrett, Sarah Hansoul, Dan L Nicolae, Judy H Cho, Richard H Duerr, John D Rioux, Steven R Brant, Mark S Silverberg, Kent D Taylor, M Michael Barmada and 54 more

2 registry-linked trialsAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1,326 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,326citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01836939 phase1completednot on this mapstarted 2013, after this paper: background citation

A Randomized Open-label Two-arm Pilot Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis. Protocol: Psoriasis IIT

TypeinterventionalSponsorMark LebwohlRan2013 to 2014Enrolled8ConditionsPsoriasisArmsTSO 2500, TSO 7500
NCT01948271 phase1terminatednot on this mapstarted 2013, after this paper: background citation

An Open-label Pilot Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis

TypeinterventionalSponsorTufts Medical CenterRan2013 to 2014Enrolled3ConditionsPsoriasisArmsTrichuris Suis Ova
3 · Its place in the literature

Who cites it

1,326 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Role of PANoptosis in intestinal diseases and its therapeutic implications.Journal of molecular medicine (Berlin, Germany) · 2026
    Review
  12. Review
  13. Article
  14. LRRK2NPJ Parkinson's disease · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,266 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

64 authors.

Jeffrey C BarrettBioinformatics and Statistical Genetics, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Sarah Hansoul
Dan L Nicolae
Judy H Cho
Richard H Duerr
John D Rioux
Steven R Brant
Mark S Silverberg
Kent D Taylor
M Michael Barmada
Alain Bitton
Themistocles Dassopoulos
Lisa Wu Datta
Todd Green
Anne M Griffiths
Emily O Kistner
Michael T Murtha
Miguel D Regueiro
Jerome I Rotter
L Philip Schumm
A Hillary Steinhart
Stephan R Targan
Ramnik J Xavier
NIDDK IBD Genetics Consortium
Cécile Libioulle
Cynthia Sandor
Mark Lathrop
Jacques Belaiche
Olivier Dewit
Ivo Gut
Simon Heath
Debby Laukens
Myriam Mni
Paul Rutgeerts
André Van Gossum
Diana Zelenika
Denis Franchimont
Jean-Pierre Hugot
Martine de Vos
Severine Vermeire
Edouard Louis
Belgian-French IBD Consortium
Wellcome Trust Case Control Consortium
Lon R Cardon
Carl A Anderson
Hazel Drummond
Elaine Nimmo
Tariq Ahmad
Natalie J Prescott
Clive M Onnie
Sheila A Fisher
Jonathan Marchini
Jilur Ghori
Suzannah Bumpstead
Rhian Gwilliam
Mark Tremelling
Panos Deloukas
John Mansfield
Derek Jewell
Jack Satsangi
Christopher G Mathew
Miles Parkes
Michel Georges
Mark J Daly

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
Inflammatory Bowel Disease Genetics Consortium Data Coordinating CenterU01DK062429 · NIDDK · YALE UNIVERSITY · PI CHO, JUDY H. · 2002 to 2016
$16.8M
Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBDU24DK062429 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ling-shiang Chuang, Ron Do · 2017 to 2026
$13.9M
Utilizing the Phenomics of IBD to Enhance Gene DiscoveryU01DK062413 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Dermot Patrick McGovern · 2002 to 2026
$12.2M
Yale University Inflammatory Bowel Disease Genetics Research CenterU01DK062422 · NIDDK · YALE UNIVERSITY · PI Ling-shiang Chuang · 2002 to 2026
$10.8M
IBD Gene Mapping by Clinical and Population SubsetsU01DK062431 · NIDDK · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Steven R Brant · 2002 to 2026
$10.7M
Universite de Montreal IBD Genetics Research CenterU01DK062432 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI John D. Rioux · 2002 to 2026
$9.6M
NIDDK IBD Genetics Consortium Genetic Research CenterU01DK062420 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUERR, RICHARD H · 2002 to 2021
$7.8M
Identification of the IBD genes on chromosomes 3p and 6pR01DK064869 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI RIOUX, JOHN D. · 2003 to 2016
$7.8M
Impact of Genetic Variability on Cellular Pathways and Host-Microbiome InteractioU01DK062423 · NIDDK · SINAI HEALTH SYSTEM · PI MARK S. SILVERBERG · 2002 to 2026
$7.5M
Genomic Approaches to Host-Pathogen InteractionsR01AI062773 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI XAVIER, RAMNIK J · 2006 to 2009
$1.4M
Chief Scientist Office CZB/4/540Medical Research Council G0000934Medical Research Council G0600329Medical Research Council G0800759NIAID NIH HHS AI06277NIAID NIH HHS R01 AI062773NIDDK NIH HHS DK064869NIDDK NIH HHS DK62413NIDDK NIH HHS DK62420NIDDK NIH HHS DK62422NIDDK NIH HHS DK62423NIDDK NIH HHS DK62429NIDDK NIH HHS DK62431NIDDK NIH HHS DK62432NIDDK NIH HHS P30 DK040561NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK064869NIDDK NIH HHS U01 DK062413NIDDK NIH HHS U01 DK062420NIDDK NIH HHS U01 DK062422NIDDK NIH HHS U01 DK062423NIDDK NIH HHS U01 DK062429NIDDK NIH HHS U01 DK062431NIDDK NIH HHS U01 DK062432NIDDK NIH HHS U24 DK062429Wellcome TrustWellcome Trust 068545/Z/02
6 · The paper itself

Abstract

Several risk factors for Crohn's disease have been identified in recent genome-wide association studies. To advance gene discovery further, we combined data from three studies on Crohn's disease (a total of 3,230 cases and 4,829 controls) and carried out replication in 3,664 independent cases with a mixture of population-based and family-based controls. The results strongly confirm 11 previously reported loci and provide genome-wide significant evidence for 21 additional loci, including the regions containing STAT3, JAK2, ICOSLG, CDKAL1 and ITLN1. The expanded molecular understanding of the basis of this disease offers promise for informed therapeutic development.

Indexed as

Genetic Predisposition to DiseaseGenome, HumanQuantitative Trait LociCrohn DiseaseHumans

Identifiers

PMID18587394
PMCPMC2574810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.